Annual Net Income:
-$88.88M+$137.66M(+60.77%)Summary
- As of today, BCRX annual net profit is -$88.88 million, with the most recent change of +$137.66 million (+60.77%) on December 31, 2024.
- During the last 3 years, BCRX annual net income has risen by +$95.18 million (+51.71%).
- BCRX annual net income is now -1757.45% below its all-time high of -$4.79 million, reached on December 31, 1998.
Performance
BCRX Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Net Income:
$5.08M+$5.05M(+15790.63%)Summary
- As of today, BCRX quarterly net profit is $5.08 million, with the most recent change of +$5.05 million (+15790.63%) on June 30, 2025.
- Over the past year, BCRX quarterly net income has increased by +$17.76 million (+140.12%).
- BCRX quarterly net income is now -66.44% below its all-time high of $15.15 million, reached on December 31, 2009.
Performance
BCRX Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM Net Income:
-$35.71M+$17.76M(+33.21%)Summary
- As of today, BCRX TTM net profit is -$35.71 million, with the most recent change of +$17.76 million (+33.21%) on June 30, 2025.
- Over the past year, BCRX TTM net income has increased by +$110.22 million (+75.53%).
- BCRX TTM net income is now -5862.77% below its all-time high of -$598.90 thousand, reached on March 31, 2000.
Performance
BCRX TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Net Income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
BCRX Net Income Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +60.8% | +140.1% | +75.5% |
| 3Y3 Years | +51.7% | +108.6% | +83.0% |
| 5Y5 Years | +18.4% | +113.2% | +71.4% |
BCRX Net Income Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +64.0% | at high | +106.8% | at high | +85.5% |
| 5Y | 5-Year | at high | +64.0% | at high | +106.8% | at high | +85.5% |
| All-Time | All-Time | -1757.5% | +64.0% | -66.4% | +106.8% | -5862.8% | +85.5% |
BCRX Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $5.08M(>+9900.0%) | -$35.71M(+33.2%) |
| Mar 2025 | - | $32.00K(+100.1%) | -$53.47M(+39.8%) |
| Dec 2024 | -$88.88M(+60.8%) | -$26.80M(-90.9%) | -$88.88M(+28.2%) |
| Sep 2024 | - | -$14.03M(-10.7%) | -$123.82M(+15.2%) |
| Jun 2024 | - | -$12.67M(+64.2%) | -$145.93M(+30.0%) |
| Mar 2024 | - | -$35.38M(+42.7%) | -$208.59M(+7.9%) |
| Dec 2023 | -$226.54M(+8.3%) | -$61.73M(-70.8%) | -$226.54M(+4.2%) |
| Sep 2023 | - | -$36.15M(+52.0%) | -$236.35M(+2.6%) |
| Jun 2023 | - | -$75.33M(-41.2%) | -$242.72M(-7.3%) |
| Mar 2023 | - | -$53.33M(+25.5%) | -$226.25M(+8.4%) |
| Dec 2022 | -$247.12M(-34.3%) | -$71.54M(-68.3%) | -$247.12M(-27.8%) |
| Sep 2022 | - | -$42.52M(+27.8%) | -$193.35M(+7.8%) |
| Jun 2022 | - | -$58.86M(+20.7%) | -$209.63M(-8.1%) |
| Mar 2022 | - | -$74.20M(-317.3%) | -$193.97M(-5.4%) |
| Dec 2021 | -$184.06M(-0.7%) | -$17.78M(+69.8%) | -$184.06M(+18.8%) |
| Sep 2021 | - | -$58.80M(-36.1%) | -$226.78M(-5.9%) |
| Jun 2021 | - | -$43.20M(+32.8%) | -$214.09M(-2.2%) |
| Mar 2021 | - | -$64.28M(-6.3%) | -$209.50M(-14.6%) |
| Dec 2020 | -$182.81M(-67.9%) | -$60.49M(-31.2%) | -$182.81M(-46.3%) |
| Sep 2020 | - | -$46.12M(-19.4%) | -$124.94M(-7.3%) |
| Jun 2020 | - | -$38.61M(-2.7%) | -$116.42M(-0.8%) |
| Mar 2020 | - | -$37.60M(-1334.0%) | -$115.44M(-6.0%) |
| Dec 2019 | -$108.90M(-7.6%) | -$2.62M(+93.0%) | -$108.90M(+18.6%) |
| Sep 2019 | - | -$37.59M(+0.1%) | -$133.71M(-6.4%) |
| Jun 2019 | - | -$37.63M(-21.2%) | -$125.71M(-18.0%) |
| Mar 2019 | - | -$31.05M(-13.2%) | -$106.53M(-5.2%) |
| Dec 2018 | -$101.25M(-53.9%) | -$27.43M(+7.3%) | -$101.25M(-8.4%) |
| Sep 2018 | - | -$29.60M(-60.5%) | -$93.36M(-18.3%) |
| Jun 2018 | - | -$18.45M(+28.4%) | -$78.90M(-2.0%) |
| Mar 2018 | - | -$25.78M(-31.9%) | -$77.34M(-17.6%) |
| Dec 2017 | -$65.78M(-19.3%) | -$19.54M(-29.1%) | -$65.78M(-29.6%) |
| Sep 2017 | - | -$15.13M(+10.4%) | -$50.74M(-7.7%) |
| Jun 2017 | - | -$16.89M(-18.8%) | -$47.14M(-1.3%) |
| Mar 2017 | - | -$14.22M(-215.8%) | -$46.53M(+15.6%) |
| Dec 2016 | -$55.14M(-28.2%) | -$4.50M(+60.9%) | -$55.14M(-8.9%) |
| Sep 2016 | - | -$11.53M(+29.2%) | -$50.64M(+5.8%) |
| Jun 2016 | - | -$16.28M(+28.7%) | -$53.73M(-65.1%) |
| Mar 2016 | - | -$22.83M(-56.2%) | -$32.55M(+11.0%) |
| Dec 2015 | -$43.02M(+4.8%) | - | - |
| Sep 2015 | - | -$14.62M(-398.3%) | -$36.56M(-19.2%) |
| Jun 2015 | - | $4.90M(+132.3%) | -$30.67M(+38.9%) |
| Mar 2015 | - | -$15.16M(-29.9%) | -$50.22M(-11.1%) |
| Dec 2014 | -$45.19M(-50.1%) | -$11.67M(-33.7%) | -$45.19M(-16.0%) |
| Sep 2014 | - | -$8.73M(+40.4%) | -$38.95M(-1.9%) |
| Jun 2014 | - | -$14.65M(-44.5%) | -$38.22M(-6.9%) |
| Mar 2014 | - | -$10.14M(-86.7%) | -$35.74M(-18.7%) |
| Dec 2013 | -$30.11M(+23.0%) | -$5.43M(+32.1%) | -$30.11M(+15.7%) |
| Sep 2013 | - | -$8.00M(+34.3%) | -$35.73M(+4.5%) |
| Jun 2013 | - | -$12.17M(-170.1%) | -$37.43M(+0.3%) |
| Mar 2013 | - | -$4.51M(+59.2%) | -$37.53M(+4.0%) |
| Dec 2012 | -$39.08M(+31.4%) | -$11.05M(-13.9%) | -$39.08M(+5.2%) |
| Sep 2012 | - | -$9.70M(+21.0%) | -$41.22M(+10.4%) |
| Jun 2012 | - | -$12.28M(-102.8%) | -$45.98M(+8.0%) |
| Mar 2012 | - | -$6.05M(+54.1%) | -$49.97M(+12.2%) |
| Dec 2011 | -$56.95M(-68.2%) | -$13.19M(+8.8%) | -$56.95M(-7.8%) |
| Sep 2011 | - | -$14.46M(+11.1%) | -$52.84M(-7.3%) |
| Jun 2011 | - | -$16.27M(-24.9%) | -$49.24M(-14.1%) |
| Mar 2011 | - | -$13.03M(-43.5%) | -$43.16M(-31.9%) |
| Dec 2010 | -$33.85M(-151.7%) | -$9.08M(+16.4%) | -$32.73M(-285.0%) |
| Sep 2010 | - | -$10.86M(-6.6%) | -$8.50M(-2.9%) |
| Jun 2010 | - | -$10.19M(-292.8%) | -$8.26M(-22.3%) |
| Mar 2010 | - | -$2.60M(-117.1%) | -$6.75M(+49.8%) |
| Dec 2009 | -$13.45M | $15.15M(+242.6%) | -$13.45M(+27.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2009 | - | -$10.63M(-22.4%) | -$18.53M(-9.7%) |
| Jun 2009 | - | -$8.68M(+6.5%) | -$16.90M(+19.2%) |
| Mar 2009 | - | -$9.29M(-192.3%) | -$20.93M(+15.4%) |
| Dec 2008 | -$24.73M(+14.9%) | $10.07M(+212.0%) | -$24.73M(+33.3%) |
| Sep 2008 | - | -$8.99M(+29.2%) | -$37.09M(+5.1%) |
| Jun 2008 | - | -$12.71M(+3.0%) | -$39.07M(-17.2%) |
| Mar 2008 | - | -$13.10M(-473.7%) | -$33.33M(-14.7%) |
| Dec 2007 | -$29.06M(+33.4%) | -$2.28M(+79.2%) | -$29.05M(+21.1%) |
| Sep 2007 | - | -$10.98M(-57.7%) | -$36.82M(+11.1%) |
| Jun 2007 | - | -$6.96M(+21.1%) | -$41.44M(+7.0%) |
| Mar 2007 | - | -$8.82M(+12.2%) | -$44.56M(-2.2%) |
| Dec 2006 | -$43.62M(-67.1%) | -$10.05M(+35.6%) | -$43.62M(-7.1%) |
| Sep 2006 | - | -$15.60M(-54.7%) | -$40.73M(-24.3%) |
| Jun 2006 | - | -$10.08M(-27.9%) | -$32.77M(-15.7%) |
| Mar 2006 | - | -$7.88M(-10.1%) | -$28.34M(-8.6%) |
| Dec 2005 | -$26.10M(-23.7%) | -$7.16M(+6.3%) | -$26.10M(-7.9%) |
| Sep 2005 | - | -$7.64M(-35.4%) | -$24.18M(-10.8%) |
| Jun 2005 | - | -$5.65M(-0.1%) | -$21.83M(-2.8%) |
| Mar 2005 | - | -$5.64M(-7.7%) | -$21.24M(-0.9%) |
| Dec 2004 | -$21.10M(-66.2%) | -$5.24M(+1.0%) | -$21.06M(-10.4%) |
| Sep 2004 | - | -$5.30M(-4.7%) | -$19.07M(-11.0%) |
| Jun 2004 | - | -$5.06M(+7.4%) | -$17.18M(-11.7%) |
| Mar 2004 | - | -$5.46M(-68.0%) | -$15.37M(-21.1%) |
| Dec 2003 | -$12.70M(+25.0%) | -$3.25M(+4.6%) | -$12.70M(-4.2%) |
| Sep 2003 | - | -$3.41M(-4.8%) | -$12.19M(+0.0%) |
| Jun 2003 | - | -$3.25M(-16.6%) | -$12.19M(+13.5%) |
| Mar 2003 | - | -$2.79M(-1.9%) | -$14.10M(+16.7%) |
| Dec 2002 | -$16.93M(-239.5%) | -$2.74M(+19.9%) | -$16.93M(+11.7%) |
| Sep 2002 | - | -$3.42M(+33.8%) | -$19.17M(-25.0%) |
| Jun 2002 | - | -$5.16M(+8.1%) | -$15.34M(-66.4%) |
| Mar 2002 | - | -$5.62M(-12.8%) | -$9.22M(-84.9%) |
| Dec 2001 | -$4.99M(+9.2%) | -$4.98M(-1293.8%) | -$4.99M(-169.5%) |
| Sep 2001 | - | $417.00K(-56.5%) | -$1.85M(+52.7%) |
| Jun 2001 | - | $958.00K(+169.3%) | -$3.91M(+43.0%) |
| Mar 2001 | - | -$1.38M(+24.9%) | -$6.86M(-89.5%) |
| Dec 2000 | -$5.49M(-3.6%) | -$1.84M(-12.1%) | -$3.62M(-103.5%) |
| Sep 2000 | - | -$1.64M(+17.6%) | -$1.78M(+24.0%) |
| Jun 2000 | - | -$2.00M(-207.4%) | -$2.34M(-291.2%) |
| Mar 2000 | - | $1.86M(+184.2%) | -$598.90K(+90.5%) |
| Dec 1999 | -$5.30M(-10.7%) | - | - |
| Sep 1999 | - | -$2.21M(-778.9%) | -$6.32M(-336.2%) |
| Jun 1999 | - | -$251.00K(+89.5%) | -$1.45M(+65.3%) |
| Mar 1999 | - | -$2.40M(-63.8%) | -$4.18M(+12.6%) |
| Dec 1998 | -$4.79M(+54.9%) | -$1.47M(-154.9%) | -$4.78M(+23.1%) |
| Sep 1998 | - | $2.67M(+189.5%) | -$6.22M(+45.4%) |
| Jun 1998 | - | -$2.98M(+0.8%) | -$11.39M(-8.4%) |
| Mar 1998 | - | -$3.01M(-3.6%) | -$10.51M(+0.9%) |
| Dec 1997 | -$10.62M(-37.9%) | -$2.90M(-16.0%) | -$10.60M(-8.2%) |
| Sep 1997 | - | -$2.50M(-19.0%) | -$9.80M(0.0%) |
| Jun 1997 | - | -$2.10M(+32.3%) | -$9.80M(-10.1%) |
| Mar 1997 | - | -$3.10M(-47.6%) | -$8.90M(-15.6%) |
| Dec 1996 | -$7.70M(+10.2%) | -$2.10M(+16.0%) | -$7.70M(+1.3%) |
| Sep 1996 | - | -$2.50M(-108.3%) | -$7.80M(-8.3%) |
| Jun 1996 | - | -$1.20M(+36.8%) | -$7.20M(+5.3%) |
| Mar 1996 | - | -$1.90M(+13.6%) | -$7.60M(+11.6%) |
| Dec 1995 | -$8.58M(-23.6%) | -$2.20M(-15.8%) | -$8.60M(-4.9%) |
| Sep 1995 | - | -$1.90M(-18.8%) | -$8.20M(-3.8%) |
| Jun 1995 | - | -$1.60M(+44.8%) | -$7.90M(+3.7%) |
| Mar 1995 | - | -$2.90M(-61.1%) | -$8.20M(-18.8%) |
| Dec 1994 | -$6.94M | -$1.80M(-12.5%) | -$6.90M(-35.3%) |
| Sep 1994 | - | -$1.60M(+15.8%) | -$5.10M(-45.7%) |
| Jun 1994 | - | -$1.90M(-18.8%) | -$3.50M(-118.8%) |
| Mar 1994 | - | -$1.60M | -$1.60M |
FAQ
- What is BioCryst Pharmaceuticals, Inc. annual net profit?
- What is the all-time high annual net income for BioCryst Pharmaceuticals, Inc.?
- What is BioCryst Pharmaceuticals, Inc. annual net income year-on-year change?
- What is BioCryst Pharmaceuticals, Inc. quarterly net profit?
- What is the all-time high quarterly net income for BioCryst Pharmaceuticals, Inc.?
- What is BioCryst Pharmaceuticals, Inc. quarterly net income year-on-year change?
- What is BioCryst Pharmaceuticals, Inc. TTM net profit?
- What is the all-time high TTM net income for BioCryst Pharmaceuticals, Inc.?
- What is BioCryst Pharmaceuticals, Inc. TTM net income year-on-year change?
What is BioCryst Pharmaceuticals, Inc. annual net profit?
The current annual net income of BCRX is -$88.88M
What is the all-time high annual net income for BioCryst Pharmaceuticals, Inc.?
BioCryst Pharmaceuticals, Inc. all-time high annual net profit is -$4.79M
What is BioCryst Pharmaceuticals, Inc. annual net income year-on-year change?
Over the past year, BCRX annual net profit has changed by +$137.66M (+60.77%)
What is BioCryst Pharmaceuticals, Inc. quarterly net profit?
The current quarterly net income of BCRX is $5.08M
What is the all-time high quarterly net income for BioCryst Pharmaceuticals, Inc.?
BioCryst Pharmaceuticals, Inc. all-time high quarterly net profit is $15.15M
What is BioCryst Pharmaceuticals, Inc. quarterly net income year-on-year change?
Over the past year, BCRX quarterly net profit has changed by +$17.76M (+140.12%)
What is BioCryst Pharmaceuticals, Inc. TTM net profit?
The current TTM net income of BCRX is -$35.71M
What is the all-time high TTM net income for BioCryst Pharmaceuticals, Inc.?
BioCryst Pharmaceuticals, Inc. all-time high TTM net profit is -$598.90K
What is BioCryst Pharmaceuticals, Inc. TTM net income year-on-year change?
Over the past year, BCRX TTM net profit has changed by +$110.22M (+75.53%)